Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
EBOS Group Limited ( (AU:EBO) ) has provided an update.
EBOS Group Limited announced the application for quotation of 4,277 ordinary fully paid securities on the Australian Securities Exchange (ASX). These securities are issued under an employee incentive scheme, reflecting the company’s ongoing efforts to incentivize and retain talent, potentially impacting its operational capabilities and market positioning.
The most recent analyst rating on (AU:EBO) stock is a Buy with a A$39.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and pharmaceutical industry, providing a range of products and services primarily focused on healthcare distribution and logistics.
Average Trading Volume: 96,008
Technical Sentiment Signal: Buy
Current Market Cap: A$7.45B
See more data about EBO stock on TipRanks’ Stock Analysis page.